Global Personalized Medicine Biomarkers Market Size study & Forecast, by Indication (Oncology, Diabetes, Autoimmune Diseases, Cardiology, Others) by Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring) and Regional Analysis, 2022-2029
Global Personalized Medicine Biomarkers Market is valued at approximately USD 11.76 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 15.51% over the forecast period 2022-2029. Personalized medicine biomarkers are essential tools that are specially designed for the selection of suitable patients for treatment with certain drugs and allow them personalized medicine. It emphasizes on offering appropriate treatment to the right patient, at the right dose at the right time. The growing prevalence of chronic diseases, rising awareness and significance of analyzing the prognosis and selection of dose, and increasing requirement of providing early diagnosis and treatment are attributing to the market demand around the world.
The surging demand for personalized medicine is directly associated with the demand of personalized medicine biomarkers in the global market. As per Statista, it is estimated that the global market for personalized medicine was worth approximately USD 1,980 billion in 2019 and is expected to reach USD 2,770 billion by the year 2022. Accordingly, the increasing demand for personalized medicine is to create effective and safe therapies for every patient, thus, in turn, augmenting the growth of the market globally Moreover, growing investment in research & development activities, as well as technological advancements in the diagnosis and detection of chronic diseases, are presenting various lucrative opportunities over the forecasting years. However, the regulatory & reimbursement hurdles and the high capital investments and lengthy timelines for biomarker development are hampering challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Personalized Medicine Biomarkers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing availability of funding for biomarkers, increasing technological advancements, and the presence of key market players. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the availability of government funding and initiatives, growing healthcare reforms, as well as the rising usage of screening tests for cancer in the regional market space.
Major market players included in this report are:
Laboratory Corporation of America Holding
Quest Diagnostics Incorporated
Agilent Technologies, Inc.
Genome Medical, Inc.
Coriell Life Sciences.
Thermo Fisher Scientific Inc.
NeoGenomics Laboratories
Foundation Medicine, Inc.
Illumina, Inc.
Guardant Health
Recent Developments in the Market:
In June 2022, GRAIL and AstraZeneca announced the companies entered a strategic partnership with the objective of creating companion diagnostic tests that facilitates the treatment of early-stage cancer.
Global Personalized Medicine Biomarkers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Indication, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Oncology
Diabetes
Autoimmune Diseases
Cardiology
Others
By Application:
Early Detection/Screening
Diagnosis
Treatment Selection
Monitoring
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The surging demand for personalized medicine is directly associated with the demand of personalized medicine biomarkers in the global market. As per Statista, it is estimated that the global market for personalized medicine was worth approximately USD 1,980 billion in 2019 and is expected to reach USD 2,770 billion by the year 2022. Accordingly, the increasing demand for personalized medicine is to create effective and safe therapies for every patient, thus, in turn, augmenting the growth of the market globally Moreover, growing investment in research & development activities, as well as technological advancements in the diagnosis and detection of chronic diseases, are presenting various lucrative opportunities over the forecasting years. However, the regulatory & reimbursement hurdles and the high capital investments and lengthy timelines for biomarker development are hampering challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Personalized Medicine Biomarkers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing availability of funding for biomarkers, increasing technological advancements, and the presence of key market players. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the availability of government funding and initiatives, growing healthcare reforms, as well as the rising usage of screening tests for cancer in the regional market space.
Major market players included in this report are:
Laboratory Corporation of America Holding
Quest Diagnostics Incorporated
Agilent Technologies, Inc.
Genome Medical, Inc.
Coriell Life Sciences.
Thermo Fisher Scientific Inc.
NeoGenomics Laboratories
Foundation Medicine, Inc.
Illumina, Inc.
Guardant Health
Recent Developments in the Market:
In June 2022, GRAIL and AstraZeneca announced the companies entered a strategic partnership with the objective of creating companion diagnostic tests that facilitates the treatment of early-stage cancer.
Global Personalized Medicine Biomarkers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Indication, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Oncology
Diabetes
Autoimmune Diseases
Cardiology
Others
By Application:
Early Detection/Screening
Diagnosis
Treatment Selection
Monitoring
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Personalized Medicine Biomarkers Market, by Region, 2019-2029 (USD Billion)
1.2.2. Personalized Medicine Biomarkers Market, by Indication, 2019-2029 (USD Billion)
1.2.3. Personalized Medicine Biomarkers Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET DYNAMICS
3.1. Personalized Medicine Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising awareness and significance of analyzing the prognosis and selection of dose
3.1.1.2. Surging demand for personalized medicine
3.1.2. Market Challenges
3.1.2.1. Regulatory & reimbursement hurdles
3.1.2.2. High capital investments and lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Growing investment in research & development activities
3.1.3.2. Technological advancements in the diagnosis and detection of chronic diseases
CHAPTER 4. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY INDICATION
6.1. Market Snapshot
6.2. Global Personalized Medicine Biomarkers Market by Indication, Performance - Potential Analysis
6.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Diabetes
6.4.3. Autoimmune Diseases
6.4.4. Cardiology
6.4.5. Others
CHAPTER 7. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Personalized Medicine Biomarkers Market by Application, Performance - Potential Analysis
7.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
7.4.1. Early Detection/Screening
7.4.2. Diagnosis
7.4.3. Treatment Selection
7.4.4. Monitoring
CHAPTER 8. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, REGIONAL ANALYSIS
8.1. Personalized Medicine Biomarkers Market, Regional Market Snapshot
8.2. North America Personalized Medicine Biomarkers Market
8.2.1. U.S. Personalized Medicine Biomarkers Market
8.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Personalized Medicine Biomarkers Market
8.3. Europe Personalized Medicine Biomarkers Market Snapshot
8.3.1. U.K. Personalized Medicine Biomarkers Market
8.3.2. Germany Personalized Medicine Biomarkers Market
8.3.3. France Personalized Medicine Biomarkers Market
8.3.4. Spain Personalized Medicine Biomarkers Market
8.3.5. Italy Personalized Medicine Biomarkers Market
8.3.6. Rest of Europe Personalized Medicine Biomarkers Market
8.4. Asia-Pacific Personalized Medicine Biomarkers Market Snapshot
8.4.1. China Personalized Medicine Biomarkers Market
8.4.2. India Personalized Medicine Biomarkers Market
8.4.3. Japan Personalized Medicine Biomarkers Market
8.4.4. Australia Personalized Medicine Biomarkers Market
8.4.5. South Korea Personalized Medicine Biomarkers Market
8.4.6. Rest of Asia Pacific Personalized Medicine Biomarkers Market
8.5. Latin America Personalized Medicine Biomarkers Market Snapshot
8.5.1. Brazil Personalized Medicine Biomarkers Market
8.5.2. Mexico Personalized Medicine Biomarkers Market
8.5.3. Rest of Latin America Personalized Medicine Biomarkers Market
8.6. Rest of The World Personalized Medicine Biomarkers Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Laboratory Corporation of America Holding
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Quest Diagnostics Incorporated
9.2.3. Agilent Technologies, Inc.
9.2.4. Genome Medical, Inc.
9.2.5. Coriell Life Sciences.
9.2.6. Thermo Fisher Scientific Inc.
9.2.7. NeoGenomics Laboratories
9.2.8. Foundation Medicine, Inc.
9.2.9. Illumina, Inc.
9.2.10. Guardant Health
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Personalized Medicine Biomarkers Market, by Region, 2019-2029 (USD Billion)
1.2.2. Personalized Medicine Biomarkers Market, by Indication, 2019-2029 (USD Billion)
1.2.3. Personalized Medicine Biomarkers Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET DYNAMICS
3.1. Personalized Medicine Biomarkers Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising awareness and significance of analyzing the prognosis and selection of dose
3.1.1.2. Surging demand for personalized medicine
3.1.2. Market Challenges
3.1.2.1. Regulatory & reimbursement hurdles
3.1.2.2. High capital investments and lengthy timelines for biomarker development
3.1.3. Market Opportunities
3.1.3.1. Growing investment in research & development activities
3.1.3.2. Technological advancements in the diagnosis and detection of chronic diseases
CHAPTER 4. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY INDICATION
6.1. Market Snapshot
6.2. Global Personalized Medicine Biomarkers Market by Indication, Performance - Potential Analysis
6.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Diabetes
6.4.3. Autoimmune Diseases
6.4.4. Cardiology
6.4.5. Others
CHAPTER 7. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Personalized Medicine Biomarkers Market by Application, Performance - Potential Analysis
7.3. Global Personalized Medicine Biomarkers Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Personalized Medicine Biomarkers Market, Sub Segment Analysis
7.4.1. Early Detection/Screening
7.4.2. Diagnosis
7.4.3. Treatment Selection
7.4.4. Monitoring
CHAPTER 8. GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET, REGIONAL ANALYSIS
8.1. Personalized Medicine Biomarkers Market, Regional Market Snapshot
8.2. North America Personalized Medicine Biomarkers Market
8.2.1. U.S. Personalized Medicine Biomarkers Market
8.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Personalized Medicine Biomarkers Market
8.3. Europe Personalized Medicine Biomarkers Market Snapshot
8.3.1. U.K. Personalized Medicine Biomarkers Market
8.3.2. Germany Personalized Medicine Biomarkers Market
8.3.3. France Personalized Medicine Biomarkers Market
8.3.4. Spain Personalized Medicine Biomarkers Market
8.3.5. Italy Personalized Medicine Biomarkers Market
8.3.6. Rest of Europe Personalized Medicine Biomarkers Market
8.4. Asia-Pacific Personalized Medicine Biomarkers Market Snapshot
8.4.1. China Personalized Medicine Biomarkers Market
8.4.2. India Personalized Medicine Biomarkers Market
8.4.3. Japan Personalized Medicine Biomarkers Market
8.4.4. Australia Personalized Medicine Biomarkers Market
8.4.5. South Korea Personalized Medicine Biomarkers Market
8.4.6. Rest of Asia Pacific Personalized Medicine Biomarkers Market
8.5. Latin America Personalized Medicine Biomarkers Market Snapshot
8.5.1. Brazil Personalized Medicine Biomarkers Market
8.5.2. Mexico Personalized Medicine Biomarkers Market
8.5.3. Rest of Latin America Personalized Medicine Biomarkers Market
8.6. Rest of The World Personalized Medicine Biomarkers Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Laboratory Corporation of America Holding
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Quest Diagnostics Incorporated
9.2.3. Agilent Technologies, Inc.
9.2.4. Genome Medical, Inc.
9.2.5. Coriell Life Sciences.
9.2.6. Thermo Fisher Scientific Inc.
9.2.7. NeoGenomics Laboratories
9.2.8. Foundation Medicine, Inc.
9.2.9. Illumina, Inc.
9.2.10. Guardant Health
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Personalized Medicine Biomarkers Market, report scope
TABLE 2. Global Personalized Medicine Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Personalized Medicine Biomarkers Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 4. Global Personalized Medicine Biomarkers Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Personalized Medicine Biomarkers Market
TABLE 70. List of primary sources, used in the study of global Personalized Medicine Biomarkers Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Personalized Medicine Biomarkers Market, report scope
TABLE 2. Global Personalized Medicine Biomarkers Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Personalized Medicine Biomarkers Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 4. Global Personalized Medicine Biomarkers Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Personalized Medicine Biomarkers Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Personalized Medicine Biomarkers Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Personalized Medicine Biomarkers Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Personalized Medicine Biomarkers Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Personalized Medicine Biomarkers Market
TABLE 70. List of primary sources, used in the study of global Personalized Medicine Biomarkers Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Personalized Medicine Biomarkers Market, research methodology
FIG 2. Global Personalized Medicine Biomarkers Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Personalized Medicine Biomarkers Market, key trends 2021
FIG 5. Global Personalized Medicine Biomarkers Market, growth prospects 2022-2029
FIG 6. Global Personalized Medicine Biomarkers Market, porters 5 force model
FIG 7. Global Personalized Medicine Biomarkers Market, pest analysis
FIG 8. Global Personalized Medicine Biomarkers Market, value chain analysis
FIG 9. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Personalized Medicine Biomarkers Market, regional snapshot 2019 & 2029
FIG 15. North America Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 16. Europe Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 19. Global Personalized Medicine Biomarkers Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Personalized Medicine Biomarkers Market, research methodology
FIG 2. Global Personalized Medicine Biomarkers Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Personalized Medicine Biomarkers Market, key trends 2021
FIG 5. Global Personalized Medicine Biomarkers Market, growth prospects 2022-2029
FIG 6. Global Personalized Medicine Biomarkers Market, porters 5 force model
FIG 7. Global Personalized Medicine Biomarkers Market, pest analysis
FIG 8. Global Personalized Medicine Biomarkers Market, value chain analysis
FIG 9. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Personalized Medicine Biomarkers Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Personalized Medicine Biomarkers Market, regional snapshot 2019 & 2029
FIG 15. North America Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 16. Europe Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Personalized Medicine Biomarkers Market 2019 & 2029 (USD Billion)
FIG 19. Global Personalized Medicine Biomarkers Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
